Company News

Business update

Fortunate to be nominated by the business and industry community, Alagate Limited has awarded as HONG KONG'S MOST OUTSTANDING BUSINESS AWARDS 2022-《Most Outstanding Consultancy Service Of Chinese Medicine and Food Supplement Industries》in 2022.

 
Company News

Business update

Fortunate to be nominated by the business and industry community, Alagate Limited has awarded as Asia's Most Valuable Companies in Hong Kong Awards 2022-《Asia’s Most Innovative Drugs Testing & Certification Services》in 2022.

See how their innovation is helping the healthcare sector save lives on

Mediazone - Facebook - Instagram - Twitter - LinkedIn

 
Company News

Business update

Our CEO, Dr. Albert Tsang has invited by Shui On-Yau Lee Joint Venture as Consultant for providing Laboratory Consultancy on Design and Construction of Chinese Medicine Hospital and Government Chinese Medicines Testing Institute in Tseung Kwan O.

 
Company News

Business update

Alagate has been successfully granted for more than 135 client’s HKP/HKC products from Chinese Medicine Development Fund

艾爾奇已成功協助客戶的135種 HKP / HKC產品獲得中藥發展基金資助註冊

 
Company news

Chinese Medicine Registration Supporting Scheme-Service Provider

Alagate has been successfully registered as Chinese Medicine Development Fund (香港中醫藥發展基金) Proprietary Chinese Medicine Registration Supporting Scheme-Service Provider (「中成藥註冊支援計劃」服務提供者) (Registration No.登記編號:19A3C0002).

Detail
HKSAR the Department of Health

Sulphur dioxide residue in Chinese herbal medicines and related measures for implementation

Consultation document on "setting limits of sulphur dioxide residue in Chinese herbal medicines and related measures for implementation".

衞生署有關制定中藥材二氧化硫殘留限度及相關執行方案的建議

Detail
HKSAR the Department of Health

Proprietary Chinese medicine

Proposal on amendment of the definition of "proprietary Chinese medicine" under "Chinese Medicine Ordinance (Cap.549)" (Chinese version only)

衞生署修訂《中醫藥條例》 中成藥定義座談會 及 建議修訂《中醫藥條例》(第549章) 內容

Detail
Company News

Chinese Medicines Registration Discussion

represent Chinese medicines industry to invite Dr. TSUI Lok-Kin (Assistant Director, Traditional Chinese Medicine) of Department of Health to discuss the difficulties and problems on Chinese Medicines registration.

代表中藥業界約見徐樂堅醫生(中醫藥事務部助理署長)討論有關中成藥註冊制度中業界遇到之問題

Company News

Business update

Our CEO, Dr. Albert Tsang has invited by Po Leung Kuk Ngan Po Ling College as School Consultant for the development of Chinese Medicine Testing Centre and its applications on the studies of Chinese Medicines.

本公司之行政總裁曾銳博士,獲保良局顏寶鈴書院邀請擔任為學校顧問。為全港首間中學中藥研究中心之發展及應用提供專業意見。

Detail